Safety and immunovirologic outcomes with maraviroc combination regimens in patients with a history of past treatment failures and virologic resistance in Brazil: an open-label, multicenter phase 3b study.
about
Safety and immunovirologic outcomes with maraviroc combination regimens in patients with a history of past treatment failures and virologic resistance in Brazil: an open-label, multicenter phase 3b study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Safety and immunovirologic out ...... l, multicenter phase 3b study.
@en
Safety and immunovirologic out ...... l, multicenter phase 3b study.
@nl
type
label
Safety and immunovirologic out ...... l, multicenter phase 3b study.
@en
Safety and immunovirologic out ...... l, multicenter phase 3b study.
@nl
prefLabel
Safety and immunovirologic out ...... l, multicenter phase 3b study.
@en
Safety and immunovirologic out ...... l, multicenter phase 3b study.
@nl
P2093
P356
P1476
Safety and immunovirologic out ...... l, multicenter phase 3b study.
@en
P2093
Antônio F B Miranda
Breno R Santos
Dalia B Wajsbrot
David S Lewi
Eliana L Bicudo
José L de Andrade Neto
José V Madruga
Juvencio Furtado
Lourenia M Cassoli
Margareth da Eira
P304
P356
10.1089/AID.2012.0330
P577
2013-06-25T00:00:00Z